Intermittent claudication: next-generation therapy

Intermittent claudication: next-generation therapy

Given that existing therapies for intermittent claudication are not appropriate for all patients, researchers are working to develop new therapies focused on improving patients’ ability to compensate for a vascular occlusion by expanding collateral artery pathways.

By Steven J. Miller, PhD; A. George Akingba, MD, PhD; and Joseph L. Unthank, PhD 

read more

Join

Subscribe For Updates

Stay in the loop with the latest news and updates! Subscribe now to receive exclusive content, special offers, and important announcements straight to your inbox. Don’t miss out – join our community today for all the latest updates delivered directly to you.